0 avis
Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma
Archive ouverte
Edité par CCSD ; John Libbey Eurotext -
International audience. Vismodegib is indicated for the treatment of advanced or metastatic basal cell carcinoma (BCC). The predictive factors of response to vismodegib have so far been poorly described.